Two Sigma Investments, LP Vanda Pharmaceuticals Inc. Transaction History

Two Sigma Investments, LP

  • $41.6 Billion
  • Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 199,460 shares of VNDA stock, worth $937,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199,460
Previous 102,443 94.7%
Holding current value
$937,462
Previous $480,000 98.96%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$4.41 - $5.46 $427,844 - $529,712
97,017 Added 94.7%
199,460 $955,000
Q3 2024

Nov 14, 2024
BUY
$4.61 - $6.34 $76,867 - $105,713
16,674 Added 19.44%
102,443 $480,000
Q2 2024

Aug 14, 2024
SELL
$3.91 - $6.5 $1.75 Million - $2.9 Million
-446,511 Reduced 83.89%
85,769 $484,000
Q1 2024

May 15, 2024
SELL
$3.47 - $4.61 $870,012 - $1.16 Million
-250,724 Reduced 32.02%
532,280 $2.19 Million
Q4 2023

Feb 14, 2024
BUY
$3.38 - $4.58 $606,547 - $821,890
179,452 Added 29.73%
783,004 $3.3 Million
Q3 2023

Nov 14, 2023
SELL
$4.28 - $6.57 $280,476 - $430,545
-65,532 Reduced 9.79%
603,552 $2.61 Million
Q2 2023

Aug 14, 2023
BUY
$5.9 - $6.95 $948,885 - $1.12 Million
160,828 Added 31.64%
669,084 $4.41 Million
Q1 2023

May 15, 2023
BUY
$6.18 - $7.99 $382,449 - $494,461
61,885 Added 13.86%
508,256 $3.45 Million
Q4 2022

Feb 14, 2023
BUY
$6.87 - $10.96 $617,248 - $984,723
89,847 Added 25.2%
446,371 $3.3 Million
Q3 2022

Nov 14, 2022
SELL
$9.44 - $11.76 $498,847 - $621,445
-52,844 Reduced 12.91%
356,524 $3.52 Million
Q2 2022

Aug 15, 2022
BUY
$9.31 - $11.84 $989,047 - $1.26 Million
106,235 Added 35.05%
409,368 $4.46 Million
Q1 2022

May 16, 2022
SELL
$10.84 - $16.55 $304,885 - $465,485
-28,126 Reduced 8.49%
303,133 $3.43 Million
Q4 2021

Feb 14, 2022
BUY
$15.69 - $21.14 $3.28 Million - $4.42 Million
209,014 Added 170.98%
331,259 $5.2 Million
Q3 2021

Nov 15, 2021
SELL
$15.35 - $21.27 $1.87 Million - $2.59 Million
-121,596 Reduced 49.87%
122,245 $2.1 Million
Q2 2021

Aug 16, 2021
BUY
$15.71 - $21.51 $993,720 - $1.36 Million
63,254 Added 35.03%
243,841 $5.25 Million
Q1 2021

May 17, 2021
BUY
$13.42 - $20.28 $1.78 Million - $2.68 Million
132,330 Added 274.22%
180,587 $2.71 Million
Q4 2020

Feb 16, 2021
BUY
$9.77 - $13.81 $471,470 - $666,429
48,257 New
48,257 $634,000
Q3 2020

Nov 16, 2020
SELL
$9.32 - $12.02 $978,627 - $1.26 Million
-105,003 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$9.66 - $12.02 $602,861 - $750,144
-62,408 Reduced 37.28%
105,003 $1.2 Million
Q1 2020

May 15, 2020
SELL
$7.5 - $16.8 $1.69 Million - $3.79 Million
-225,307 Reduced 57.37%
167,411 $1.73 Million
Q4 2019

Feb 14, 2020
BUY
$12.38 - $17.47 $2.01 Million - $2.83 Million
162,179 Added 70.35%
392,718 $6.45 Million
Q3 2019

Nov 14, 2019
SELL
$12.27 - $15.79 $2.59 Million - $3.34 Million
-211,463 Reduced 47.84%
230,539 $3.06 Million
Q2 2019

Aug 14, 2019
BUY
$13.37 - $18.85 $521,938 - $735,866
39,038 Added 9.69%
442,002 $6.23 Million
Q1 2019

May 15, 2019
BUY
$17.59 - $31.05 $1.38 Million - $2.44 Million
78,655 Added 24.25%
402,964 $7.42 Million
Q4 2018

Feb 14, 2019
SELL
$18.97 - $31.47 $683,868 - $1.13 Million
-36,050 Reduced 10.0%
324,309 $8.47 Million
Q3 2018

Nov 14, 2018
BUY
$18.25 - $23.0 $102,346 - $128,984
5,608 Added 1.58%
360,359 $8.27 Million
Q2 2018

Aug 14, 2018
BUY
$13.95 - $19.15 $2.52 Million - $3.45 Million
180,314 Added 103.37%
354,751 $6.76 Million
Q1 2018

May 15, 2018
BUY
$14.05 - $20.2 $2.19 Million - $3.15 Million
156,037 Added 848.03%
174,437 $2.94 Million
Q4 2017

Feb 14, 2018
SELL
$12.85 - $18.1 $2.38 Million - $3.36 Million
-185,558 Reduced 90.98%
18,400 $280,000
Q3 2017

Nov 14, 2017
BUY
$15.4 - $18.85 $3.14 Million - $3.84 Million
203,958
203,958 $3.65 Million

Others Institutions Holding VNDA

# of Institutions
155
Shares Held
43.7M
Call Options Held
33.8K
Put Options Held
28.7K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $266M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email